A2 Biotherapeutics
PrivateLast Round
Grant
May 6, 2025
Total Funding Raised
$270.8M
Momentum Score
25 /100
Company Overview
A2 Bio is a biotechnology company that specializes in cell therapies aimed at curing cancer through targeted tumor-specific approaches.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A2 Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
A2 Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Series C | Jan 9, 2025 | ||||
| Series B Extension | Dec 19, 2022 | ||||
| Series B | Oct 6, 2020 | ||||
| Series A Extension | Nov 5, 2019 |
Key People
Founding team and executive leadership
A2 Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A Extension, Series C |
| Perceptive Advisors | Series C |
| Vida Ventures | Series B, Series C, Series A Extension |
| Aisling Capital | Series C |
| Casdin Capital | Series B |
| Nextech Invest | Series B, Series A Extension |
| Samsara BioCapital | Series B, Series A Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Three abstracts accepted for presentation at the 2026 ASCO Annual Meeting.
- Oct 3, 2025
Four abstracts accepted for the Society for Immunotherapy of Cancer meeting.
A2 Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about A2 Biotherapeutics's valuation, stock price, and market status.
